Comprehensive analysis of LncRNAs expression profiles in an in vitro model of steatosis treated with Exendin-4
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Comprehensive analysis of LncRNAs expression profiles in an in vitro model of steatosis treated with Exendin-4
Authors
Keywords
-
Journal
Journal of Translational Medicine
Volume 19, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-06-02
DOI
10.1186/s12967-021-02885-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Glucagon and Glucagon-like Peptide-1 Receptors: Promising Therapeutic Targets for an Effective Management of Diabetes Mellitus
- (2020) Ghulam Abbas et al. CURRENT PHARMACEUTICAL DESIGN
- Efficacy and Safety of Liraglutide 3.0 mg in Individuals With Overweight or Obesity and Type 2 Diabetes Treated With Basal Insulin: The SCALE Insulin Randomized Controlled Trial
- (2020) W. Timothy Garvey et al. DIABETES CARE
- Molecular Mechanisms: Connections between Nonalcoholic Fatty Liver Disease, Steatohepatitis and Hepatocellular Carcinoma
- (2020) Tatsuo Kanda et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Inevitable role of TGF-β1 in progression of nonalcoholic fatty liver disease
- (2020) Bhagyalakshmi Nair et al. JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION
- Current and emerging pharmacological options for the treatment of nonalcoholic steatohepatitis
- (2020) Stergios A. Polyzos et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- New therapeutic strategies in nonalcoholic fatty liver disease: a focus on promising drugs for nonalcoholic steatohepatitis
- (2020) Natalia Pydyn et al. Pharmacological Reports
- LncRNA-NEAT1 from the competing endogenous RNA network promotes cardioprotective efficacy of mesenchymal stem cell-derived exosomes induced by macrophage migration inhibitory factor via the miR-142-3p/FOXO1 signaling pathway
- (2020) Hanbin Chen et al. Stem Cell Research & Therapy
- Long noncoding RNA CCAT1 inhibits miR‐613 to promote nonalcoholic fatty liver disease via increasing LXRα transcription
- (2020) Feizhou Huang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- The Role of Insulin Resistance and Diabetes in Nonalcoholic Fatty Liver Disease
- (2020) Hideki Fujii et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Role of Agents for the Treatment of Diabetes in the Management of Nonalcoholic Fatty Liver Disease
- (2020) Jeffrey Budd et al. Current Diabetes Reports
- Effect of dulaglutide on liver fat in patients with type 2 diabetes and NAFLD: randomised controlled trial (D-LIFT trial)
- (2020) Mohammad S. Kuchay et al. DIABETOLOGIA
- Noncoding RNAs in Nonalcoholic Fatty Liver Disease: Potential Diagnosis and Prognosis Biomarkers
- (2020) Olfa Khalifa et al. DISEASE MARKERS
- Pathophysiology of NAFLD and NASH in Experimental Models: The Role of Food Intake Regulating Peptides
- (2020) L. Kořínková et al. Frontiers in Endocrinology
- Regulatory Non-coding RNAs Network in Non-alcoholic Fatty Liver Disease
- (2019) Siti Aishah Sulaiman et al. Frontiers in Physiology
- LncRNA-H19 promotes hepatic lipogenesis by directly regulating miR-130a/PPARγ axis in nonalcoholic fatty liver disease
- (2019) Jun Liu et al. BIOSCIENCE REPORTS
- Dietary and Pharmacological Treatment of Nonalcoholic Fatty Liver Disease
- (2019) Anna Jeznach-Steinhagen et al. Medicina-Lithuania
- Long non-coding RNA H19 promotes the proliferation and invasion of lung cancer cells and regulates the expression of E-cadherin, N-cadherin, and vimentin
- (2019) Shu Liao et al. OncoTargets and Therapy
- Long non-coding RNA NEAT1 promotes steatosis via enhancement of estrogen receptor alpha-mediated AQP7 expression in HepG2 cells
- (2019) Xiaohua Fu et al. Artificial Cells Nanomedicine and Biotechnology
- Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development
- (2019) Juliette Mouries et al. JOURNAL OF HEPATOLOGY
- Role of long non-coding RNA TP73-AS1 in cancer
- (2019) Caizhi Chen et al. BIOSCIENCE REPORTS
- Multi-technique comparison of atherogenic and MCD NASH models highlights changes in sphingolipid metabolism
- (2019) Sophie A. Montandon et al. Scientific Reports
- Long non‐coding RNA (lncRNA) H19 induces hepatic steatosis through activating MLXIPL and mTORC1 networks in hepatocytes
- (2019) Hao Wang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Evolution of NAFLD and Its Management
- (2019) Manpreet S. Mundi et al. NUTRITION IN CLINICAL PRACTICE
- Improvements in clinical characteristics of patients with non-alcoholic fatty liver disease, after an intervention based on the Mediterranean lifestyle: a randomised controlled clinical trial
- (2018) Christina N. Katsagoni et al. BRITISH JOURNAL OF NUTRITION
- Functional Classification and Experimental Dissection of Long Noncoding RNAs
- (2018) Florian Kopp et al. CELL
- Future Perspectives on GLP-1 Receptor Agonists and GLP-1/glucagon Receptor Co-agonists in the Treatment of NAFLD
- (2018) Marta Seghieri et al. Frontiers in Endocrinology
- Pleiotropic Effects of GLP-1 and Analogs on Cell Signaling, Metabolism, and Function
- (2018) Jordan Rowlands et al. Frontiers in Endocrinology
- Down-regulation of lncRNA-NEAT1 alleviated the non-alcoholic fatty liver disease via mTOR/S6K1 signaling pathway
- (2017) Xiang Wang JOURNAL OF CELLULAR BIOCHEMISTRY
- LncRNAs2Pathways: Identifying the pathways influenced by a set of lncRNAs of interest based on a global network propagation method
- (2017) Junwei Han et al. Scientific Reports
- Long noncoding RNAs in cancer: mechanisms of action and technological advancements
- (2016) Nenad Bartonicek et al. Molecular Cancer
- Low simvastatin concentrations reduce oleic acid-induced steatosis in HepG2 cells: An in vitro model of non-alcoholic fatty liver disease
- (2016) MOHAMMAD J. ALKHATATBEH et al. Experimental and Therapeutic Medicine
- Exendin-4 Inhibits Hepatic Lipogenesis by Increasing β-Catenin Signaling
- (2016) Mi Hae Seo et al. PLoS One
- Long noncoding RNA MALAT1 promotes hepatic steatosis and insulin resistance by increasing nuclear SREBP-1c protein stability
- (2016) Caifeng Yan et al. Scientific Reports
- Toll-like receptor 7 affects the pathogenesis of non-alcoholic fatty liver disease
- (2016) Sokho Kim et al. Scientific Reports
- Comprehensive Profiling of Plasma Fatty Acid Concentrations in Young Healthy Canadian Adults
- (2015) Salma A. Abdelmagid et al. PLoS One
- Identification and Characterization of GLP-1 Receptor-Expressing Cells Using a New Transgenic Mouse Model
- (2013) P. Richards et al. DIABETES
- Loss of the abundant nuclear non-coding RNAMALAT1is compatible with life and development
- (2012) Moritz Eißmann et al. RNA Biology
- From the metabolic syndrome to NAFLD or vice versa?
- (2010) Ester Vanni et al. DIGESTIVE AND LIVER DISEASE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started